Skip to content
SentinelMarket desk
Switch to dark mode

아이티켐

309710KOSDAQView the 제약 sectorTheme Bio & healthcare

21,000KRWMarket close of 10/21 (Wed)

No trade that dayMarket close of 10/21 (Wed)

Volume
0×10K shares
0 KRW

Open, high and low are not shown — the source has no bar for the reference date

Market close of 10/21 (Wed)

Something to check

1 to check: no trades this day

Free · no sign-inSource from 2021-05-17

Points to check

  • Daily moveto checkNo trades this day (0 shares)
  • Trading valuenot verifiedNo trading that day, so not compared with usual trading value
  • Earningsnot verifiedThe last four quarters are incomplete, so not verified

The other 3

  • Recent filingsnot verified
  • Foreign & institutionalnot verified
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters)
  • Revenue12.7B KRWRevenue bars for the last 4 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    —
  • Operating income-1.7B KRWOperating income bars for the last 4 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    —
  • Operating margin-13.6%Operating margin bars for the last 4 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    —

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-06-01
2025Q2 -724.57 million KRW2026Q1 -1.7B KRW

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.